Table 2.
Primary tumor site, stage, pathology and initial treatment
| Primary site | Number of patients | TNM stage | AJCC stage | Pathology | Initial treatment | ORN Stage |
|---|---|---|---|---|---|---|
| |
|
T4N2 |
IVA |
SCC |
Surgery + adjuvant CCRT |
2 |
| T4N2 |
IVA |
SCC |
RT |
1 |
||
| Tonsil |
5 |
T4N1 |
IVA |
SCC |
RT |
3 |
| |
|
T2N0 |
II |
SCC |
RT |
3 |
| T2N0 |
II |
SCC |
RT |
3 |
||
| |
|
T3N0 |
III |
SCC |
Surgery + adjuvant CCRT |
2 |
| Tongue |
4 |
T3N0 |
III |
SCC |
Surgery + adjuvant RT |
1 |
| |
|
T2N2 |
IVA |
SCC |
Surgery + adjuvant CCRT |
3 |
| T2N1 |
III |
SCC |
Surgery + adjuvant RT |
2 |
||
| Retromolar trigone |
2 |
T2N0 |
II |
SCC |
RT |
1 |
| T2N0 |
II |
SCC |
RT |
1 |
||
| Parotid gland |
1 |
T2N2 |
IVA |
Adenocarcinoma |
Surgery + adjuvant RT |
3 |
| Soft palate |
1 |
T3N0 |
III |
SCC |
RT |
1 |
| Buccal mucosa | 1 | T2N0 | II | SCC | RT | 3 |
CCRT concomitant chemoradiotherapy, RT radiotherapy, SCC squamous cell carcinoma.